KALV · CIK 0001348911 · operating
KalVista Pharmaceuticals, Inc. (KALV) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $812 million, KalVista Pharmaceuticals, Inc. is a small-cap company. The stock currently trades at $16.06, down 1.35% today, with a 52-week range of $9.23–$19.00.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-3.69 | $-3.69 | -7.3% | |
| 2024 | $-3.44 | $-3.44 | -3.3% | |
| 2023 | $-3.33 | $-3.33 | +0.9% | |
| 2022 | $-3.36 | $-3.36 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2015 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-04-30 | 2025-07-10 | 0000950170-25-095011 | SEC ↗ |
| 2024-04-30 | 2024-07-11 | 0000950170-24-082965 | SEC ↗ |
| 2023-04-30 | 2023-07-10 | 0000950170-23-032298 | SEC ↗ |
| 2022-04-30 | 2022-07-07 | 0000950170-22-012521 | SEC ↗ |
| 2021-04-30 | 2021-07-13 | 0001564590-21-036441 | SEC ↗ |
| 2020-04-30 | 2020-07-01 | 0001564590-20-031501 | SEC ↗ |
| 2019-04-30 | 2019-07-16 | 0001564590-19-025009 | SEC ↗ |
| 2018-04-30 | 2018-07-30 | 0001564590-18-017915 | SEC ↗ |
| 2017-04-30 | 2017-07-27 | 0001564590-17-014286 | SEC ↗ |
| 2015-12-31 | 2016-03-30 | 0001564590-16-015646 | SEC ↗ |